Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Steiger

Showing results (161-170 of 370) with videos related to

Pageof 37
Sort By:
JCO Clinical Cancer Informatics|August 1, 2023
Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep LearningFabian Hörst, Saskia Ting, Sven-Thorsten Liffers, et al.
Molecular Cancer|December 20, 2015
Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinomaBo Kong, Tao Cheng, Chengjia Qian, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2025
Experimental Investigation of Hematological Toxicity After Radiation Therapy Combined With Immune Checkpoint InhibitorsVincent R Timnik, Andreas Zoeschg, Sarah Diederich, et al.
Scientific Reports|February 2, 2017
Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypesAnna Melissa Schlitter, Angela Segler, Katja Steiger, et al.
European Journal of Haematology|February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIMFlorian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Cancers|December 24, 2021
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk SubgroupsMaxime Schmitt, Miguel Silva, Björn Konukiewitz, et al.
Oncotarget|June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgroupingMoritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2024
ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and OutcomeElisa Moser, Ayako Ura, Loreen Vogel, et al.
Neoplasia (New York, N.Y.)|January 25, 2025
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.
Nature Communications|August 15, 2023
mRNA 3'UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virusValter Bergant, Daniel Schnepf, Niklas de Andrade Krätzig, et al.
Pageof 37

Showing results (161-170 of 370) with videos related to

Sort By:
Pageof 37
JCO Clinical Cancer Informatics|August 1, 2023
Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep LearningFabian Hörst, Saskia Ting, Sven-Thorsten Liffers, et al.
Molecular Cancer|December 20, 2015
Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinomaBo Kong, Tao Cheng, Chengjia Qian, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2025
Experimental Investigation of Hematological Toxicity After Radiation Therapy Combined With Immune Checkpoint InhibitorsVincent R Timnik, Andreas Zoeschg, Sarah Diederich, et al.
Scientific Reports|February 2, 2017
Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypesAnna Melissa Schlitter, Angela Segler, Katja Steiger, et al.
European Journal of Haematology|February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIMFlorian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Cancers|December 24, 2021
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk SubgroupsMaxime Schmitt, Miguel Silva, Björn Konukiewitz, et al.
Oncotarget|June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgroupingMoritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2024
ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and OutcomeElisa Moser, Ayako Ura, Loreen Vogel, et al.
Neoplasia (New York, N.Y.)|January 25, 2025
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.
Nature Communications|August 15, 2023
mRNA 3'UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virusValter Bergant, Daniel Schnepf, Niklas de Andrade Krätzig, et al.
Pageof 37